New treatment option for prostate cancer shows successful outcomes
Retrieved on:
Saturday, March 23, 2024
Disease, Radiation, Cryotherapy, Hatred, Collateral damage, MRI, Prostate cancer, Average revenue per user, Urology, Heat, FASR, Risk, Patient, Lung, Neoplasm, Research, Cancer, Calcification, Standard of care, Radiology, Prostate, Society, Urinary incontinence, Kidney, Erectile dysfunction, PCA, PSA, UCLA, Urethra, Medical imaging
FAIRFAX, Va., March 23, 2024 /PRNewswire/ -- A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting in Salt Lake City.
Key Points:
- "Prostate cancer is the most common form of cancer in men, affecting one in eight men in their lifetimes.
- According to Dr. Raman, "This image-guided therapy maximizes our ability to kill cancer cells while minimizing collateral damage to the prostate to achieve the ultimate trifecta in prostate cancer treatment: full local cancer control while maintaining urinary continence and potency.
- The latter are the complications of most prostate cancer therapies that patients hate and often result from a lack of precision in treatment monitoring."
- Abstract #135 : Five-year outcomes after MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer.